Interleukin-2 for use in treating autism spectrum disorder
AssigneesInserm (Institut National De La Santé Et La Recherche MéDicale), Sorbonne Universite, Assistance Publique-Hopitaux de Paris
InventorsDavid Klaatzman, Pierre Ellul, Michelle Rosenzwajg, Richard Delorme, Gwladys Fourcade
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of IL-2 in treating autism spectrum disorder (ASD) in a subject, as well as in preventing ASD in children, by administering the IL-2 to a child at risk of ASD or to a pregnant mother at risk of having a child with ASD.
Claims15
Interleukin-2 (IL-2) for use in treating autism spectrum disorder (ASD) in a subject.
Interleukin-2 (IL-2) for use in preventing autism spectrum disorder (ASD) in a subject, wherein the IL-2 is administered to the subject who is an infant or a child, preferably wherein the infant or child is at risk of ASD.
Interleukin-2 (IL-2) for use in preventing autism spectrum disorder (ASD) in an infant or a child, wherein the IL-2 is administered to a pregnant mother.
Dependencies are inferred from the claim text.